You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Colorcon
Mallinckrodt
Boehringer Ingelheim
Express Scripts

Last Updated: February 19, 2020

DrugPatentWatch Database Preview

Sucralfate - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic sources for sucralfate and what is the scope of patent protection?

Sucralfate is the generic ingredient in two branded drugs marketed by Allergan, Amneal Pharms Llc, Nostrum Labs Inc, and Teva, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for sucralfate. Twenty-three suppliers are listed for this compound.

Drug Prices for sucralfate

See drug prices for sucralfate

Drug Sales Revenue Trends for sucralfate

See drug sales revenues for sucralfate

Recent Clinical Trials for sucralfate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Texas at AustinPhase 2
Taipei Veterans General Hospital, TaiwanN/A
Pamukkale UniversityPhase 4

See all sucralfate clinical trials

Pharmacology for sucralfate
Medical Subject Heading (MeSH) Categories for sucralfate

US Patents and Regulatory Information for sucralfate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan CARAFATE sucralfate TABLET;ORAL 018333-001 Approved Prior to Jan 1, 1982 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Allergan CARAFATE sucralfate SUSPENSION;ORAL 019183-001 Dec 16, 1993 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Nostrum Labs Inc SUCRALFATE sucralfate TABLET;ORAL 074415-001 Jun 8, 1998 DISCN No No   Start Trial   Start Trial   Start Trial
Teva SUCRALFATE sucralfate TABLET;ORAL 070848-001 Mar 29, 1996 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Express Scripts
Baxter
Medtronic
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.